Hemoperfusion added to dialysis for kidney patients
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study is testing whether adding a special blood-filtering treatment (hemoperfusion) to your regular hemodialysis can improve outcomes for people with end-stage kidney disease. It may be a good option if you have been on dialysis for a while and have little to no remaining kidney function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on maintenance hemodialysis for at least 3 months.
- You are between 18 and 84 years old.
- You produce less than 200 milliliters of urine per day (little to no kidney function).
- You do not have a recent stroke, severe brain disease, serious heart/lung disease, or active cancer.
- You do not have a known allergy to dialysis membrane materials, and your platelet count is above 60,000.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a long-term, high-flow hemoadsorption therapy for people on maintenance hemodialysis. It aims to see if the treatment can improve outcomes for those with uremia (built-up waste in the blood).
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
This trial compares two types of dialysis—expanded hemodialysis and high-volume online hemodiafiltration—to see which removes waste products from the blood better. If you are on standard expanded hemodialysis, joining could help find the best way to clean your blood.
This study tests whether adding pea fiber to your diet can improve health outcomes in people receiving hemodialysis for kidney disease. Researchers want to see if this natural fiber helps reduce harmful substances in your blood and improves your overall well-being.
This study tests whether adding a special filter (hemoperfusion) to your regular hemodialysis can better remove waste products that build up in the blood. It might help people on dialysis feel better and have fewer complications.
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.